Parkinson's disease with homozygous PINK1 p.Leu489Pro mutations in two Indian sisters

被引:0
|
作者
Lim, Shen-Yang [1 ,2 ]
Ahmad-Annuar, Azlina [3 ]
Lohmann, Katja [4 ]
Tan, Ai Huey [1 ,2 ]
Tay, Yi Wen [3 ]
Lim, Jia Lun [2 ,3 ]
Ramli, Norlisah [5 ]
Teh, Pei Chiek [6 ]
Kuppusamy, Rishikesan [7 ]
Tan, Chong Tin [1 ]
Goh, Khean Jin [1 ]
Viswanathan, Shanthi [8 ]
Bauer, Peter [9 ]
Rolfs, Arndt [9 ]
Klein, Christine [4 ]
机构
[1] Univ Malaya, Fac Med, Div Neurol, Kuala Lumpur, Malaysia
[2] Univ Malaya, Fac Med, Mah Pooi Soo & Tan Chin Nam Ctr Parkinsons & Rela, Kuala Lumpur, Malaysia
[3] Univ Malaya, Fac Med, Dept Biomed Sci, Kuala Lumpur, Malaysia
[4] Univ Lubeck, Inst Neurogenet, Lubeck, Germany
[5] Univ Malaya, Fac Med, Div Neuroradiol, Kuala Lumpur, Malaysia
[6] Hosp Tuanku Jaafar Seremban, Seremban, Malaysia
[7] Pantai Hosp Bangsar, Kuala Lumpur, Malaysia
[8] Hosp Kuala Lumpur, Div Neurol, Kuala Lumpur, Malaysia
[9] Centogene AG, Rostock, Germany
关键词
Parkinson's disease; PINK1; genetics; Asian; Indian; clozapine; MRI; corticospinal tract;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We describe the clinical features of two sisters with Parkinson?s disease (PD) of Indian descent living in Malaysia. Both were homozygous for the known PINK1 mutation p.Leu489Pro (c.1466T>C). The proband, who has been followed up by us over a span of 35 years, had a fairly ?classic? clinical presentation for PARK-PINK1, including young onset, a clear response to dopamine replacement therapy, and development of troublesome motor fluctuations and dyskinesias. Her dyskinesias improved substantially with clozapine treatment, which to our knowledge has not specifically been reported for PARK-PINK1; this treatment has been sustained for nearly a decade. The clinical phenotype of the older sister was more akin to later-onset ?idiopathic? PD; however, her brain MRI showed abnormal signal in the posterior limb of the internal capsules and the hypothalamus. Our report contributes to the scarce literature on monogenic PD in the Malaysian / Indian population, and further supports the pathogenicity of the PINK1 p.Leu489Pro variant.
引用
收藏
页码:167 / 173
页数:7
相关论文
共 50 条
  • [41] Parkinson's Disease: Are PINK1 Activators Inching Closer to the Clinic?
    Mehellou, Youcef
    ACS MEDICINAL CHEMISTRY LETTERS, 2023, 14 (07): : 870 - 874
  • [42] Increased cysteine metabolism in PINK1 models of Parkinson's disease
    Travaglio, Marco
    Michopoulos, Filippos
    Yu, Yizhou
    Popovic, Rebeka
    Foster, Edmund
    Coen, Muireann
    Martins, L. Miguel
    DISEASE MODELS & MECHANISMS, 2023, 16 (01)
  • [43] The Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson's Disease
    Pickrell, Alicia M.
    Youle, Richard J.
    NEURON, 2015, 85 (02) : 257 - 273
  • [44] Mechanisms of neurodegeneration in Parkinson's disease: keep neurons in the PINK1
    Brunelli, Francesco
    Valente, Enza Maria
    Arena, Giuseppe
    MECHANISMS OF AGEING AND DEVELOPMENT, 2020, 189
  • [45] A new complex homozygous large rearrangement of the PINK1 gene in a Sudanese family with early onset Parkinson's disease
    Cazeneuve, Cecile
    San, Channkanira
    Ibrahim, Salah A.
    Mukhtar, Maowia M.
    Kheir, Musa M.
    LeGuern, Eric
    Brice, Alexis
    Salih, Mustafa A.
    NEUROGENETICS, 2009, 10 (03) : 265 - 270
  • [46] PARKINSON'S DISEASE: PINK1 AND MITOCHONDRIAL COMPLEX I FUNCTION
    Morais, V. A.
    Craessaerts, K.
    Aerts, L.
    Snellinx, A.
    Verstreken, P.
    De Strooper, B.
    JOURNAL OF NEUROCHEMISTRY, 2011, 118 : 20 - 21
  • [47] Dopamine Induced Neurodegeneration in a PINK1 Model of Parkinson's Disease
    Gandhi, Sonia
    Vaarmann, Annika
    Yao, Zhi
    Duchen, Michael R.
    Wood, Nicholas W.
    Abramov, Andrey Y.
    PLOS ONE, 2012, 7 (05):
  • [48] Parkinson's disease mutations in PINK1 result in decreased Complex I activity and deficient synaptic function
    Morais, Vanessa A.
    Verstreken, Patrik
    Roethig, Anne
    Smet, Joel
    Snellinx, An
    Vanbrabant, Mieke
    Haddad, Dominik
    Frezza, Christian
    Mandemakers, Wim
    Vogt-Weisenhorn, Daniela
    Van Coster, Rudy
    Wurst, Wolfgang
    Scorrano, Luca
    De Strooper, Bart
    EMBO MOLECULAR MEDICINE, 2009, 1 (02) : 99 - 111
  • [49] Biological Effects of the PINK1 P209A Mutation: Implications in Parkinson's Disease Pathogenesis
    Lee, Ming-Jen
    Wu, Ruey-Meei
    Lee, Tzeng-Ruei
    Wang, Jinyuan
    Fu, Wen-Mei
    NEUROLOGY, 2009, 72 (11) : A438 - A438
  • [50] A Novel, Population-Specific PINK1 p.F385S Loss of Function Mutation in an Indian Family with Parkinson's Disease
    Fitzgerald, J.
    Sharma, K.
    Kishore, A.
    Lechado, A.
    Raimondi, F.
    Sturm, M.
    Ashok-Kumar-Sreelatha, A.
    Kalikavil-Puthenveedu, D.
    Sarma, G.
    Casadei, N.
    Krueger, R.
    Gasser, T.
    Kahle, P.
    Riess, O.
    Sharma, M.
    MOVEMENT DISORDERS, 2023, 38 : S642 - S642